HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferase.

Abstract
2-Amino-4-oxo-6-substituted pyrrolo[2,3-d]pyrimidine antifolates with a thienoyl side chain (compounds 1-3, respectively) were synthesized for comparison with compound 4, the previous lead compound of this series. Conversion of hydroxyl acetylen-thiophene carboxylic esters to thiophenyl-α-bromomethylketones and condensation with 2,4-diamino-6-hydroxypyrimidine afforded the 6-substituted pyrrolo[2,3-d]pyrimidine compounds of type 18 and 19. Coupling with l-glutamate diethyl ester, followed by saponification, afforded 1-3. Compound 3 selectively inhibited the proliferation of cells expressing folate receptors (FRs) α or β, or the proton-coupled folate transporter (PCFT), including KB and IGROV1 human tumor cells, much more potently than 4. Compound 3 was more inhibitory than 4 toward β-glycinamide ribonucleotide formyltransferase (GARFTase). Both 3 and 4 depleted cellular ATP pools. In SCID mice with IGROV1 tumors, 3 was more efficacious than 4. Collectively, our results show potent antitumor activity for 3 in vitro and in vivo, associated with its selective membrane transport by FRs and PCFT over RFC and inhibition of GARFTase, clearly establishing the 3-atom bridge as superior to the 1-, 2-, and 4-atom bridge lengths for the activity of this series.
AuthorsLei Wang, Sita Kugel Desmoulin, Christina Cherian, Lisa Polin, Kathryn White, Juiwanna Kushner, Andreas Fulterer, Min-Hwang Chang, Shermaine Mitchell-Ryan, Mark Stout, Michael F Romero, Zhanjun Hou, Larry H Matherly, Aleem Gangjee
JournalJournal of medicinal chemistry (J Med Chem) Vol. 54 Issue 20 Pg. 7150-64 (Oct 27 2011) ISSN: 1520-4804 [Electronic] United States
PMID21879757 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Folate Receptor 1
  • Folate Receptor 2
  • Folic Acid Antagonists
  • Glutamates
  • N-((5-((2-amino-4-oxo-4,7-dihydro-3H-pyrrolo(2,3-d)pyrimidin-6-yl)propyl)thiophen-2-yl)carbonyl)glutamic acid
  • Proton-Coupled Folate Transporter
  • Pyrimidines
  • Pyrimidinones
  • Reduced Folate Carrier Protein
  • Adenosine Triphosphate
  • Phosphoribosylglycinamide Formyltransferase
Topics
  • Adenosine Triphosphate (metabolism)
  • Animals
  • Antineoplastic Agents (chemical synthesis, chemistry, pharmacology)
  • Cell Line, Tumor
  • Drug Screening Assays, Antitumor
  • Female
  • Folate Receptor 1 (metabolism)
  • Folate Receptor 2 (metabolism)
  • Folic Acid Antagonists (chemical synthesis, chemistry, pharmacology)
  • Glutamates (chemical synthesis, chemistry, pharmacology)
  • Humans
  • Mice
  • Mice, SCID
  • Neoplasm Transplantation
  • Oocytes (drug effects, physiology)
  • Patch-Clamp Techniques
  • Phosphoribosylglycinamide Formyltransferase (antagonists & inhibitors)
  • Proton-Coupled Folate Transporter (metabolism)
  • Pyrimidines (chemical synthesis, chemistry, pharmacology)
  • Pyrimidinones (chemical synthesis, chemistry, pharmacology)
  • Reduced Folate Carrier Protein (metabolism)
  • Stereoisomerism
  • Structure-Activity Relationship
  • Transplantation, Heterologous
  • Xenopus

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: